Teva Presenting Data on MS and Parkinson’s Disease Treatments – Video

Posted: Published on December 7th, 2011

This post was added by Dr Simmons



Teva Pharmaceutical Industries Ltd (TEVA) stocks are up after its announcement that it will unveil several studies supporting the efficacy and safety of it's central nervous system (CNS) products at the 63rd Annual American Academy of Neurology Meeting in Honolulu Hawaii on April 9-16, 2011. Among the featured presentations is the latest data on their pivotal Phase III trial of oral laquinimod for the treatment of relapsing-remitting multiple sclerosis, or RRMS, as well as updates on the efficacy of AZILECT on Parkinson's disease patients.

Continued here:
Teva Presenting Data on MS and Parkinson's Disease Treatments - Video

Related Posts
This entry was posted in Parkinson's Treatment. Bookmark the permalink.

Comments are closed.